Insider Sale at Vaxcyte Inc COO Jim Wassil Sells 3,000 Shares
| PCVX Stock | USD 91.70 3.16 3.57% |
Slightly above 68 percent of all Vaxcyte's investors are curious in acquiring. The analysis of the overall investor sentiment regarding Vaxcyte suggests that a large number of traders are confidant. Vaxcyte's investing sentiment can be driven by a variety of factors including economic data, Vaxcyte's earnings reports, geopolitical events, and overall market trends.
Vaxcyte |
Jim Wassil, Chief Operating Officer of Vaxcyte Inc , sold 3,000 shares of the company on June 3, 2024, according to a recent SEC Filing. Following th
Read at gurufocus.com
 |
Vaxcyte Current Investor Sentiment
Panic Vs Confidence
68
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Vaxcyte's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Vaxcyte.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
Vaxcyte Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Vaxcyte can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Vaxcyte Historical Investor Sentiment
Investor biases related to Vaxcyte's public news can be used to forecast risks associated with an investment in Vaxcyte. The trend in average sentiment can be used to explain how an investor holding Vaxcyte can time the market purely based on public headlines and social activities around Vaxcyte. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Vaxcyte's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Vaxcyte and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Vaxcyte news discussions. The higher the estimate score, the more favorable the investor's outlook on Vaxcyte.
Vaxcyte Fundamental Analysis
We analyze Vaxcyte's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaxcyte using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaxcyte based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Vaxcyte is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Vaxcyte Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vaxcyte stock to make a market-neutral strategy. Peer analysis of Vaxcyte could also be used in its relative valuation, which is a method of valuing Vaxcyte by comparing valuation metrics with similar companies.
Peers
Vaxcyte Related Equities
| MCRB | Seres Therapeutics | 15.58 | ||||
| SCPH | Scpharmaceuticals | 1.79 | ||||
| MIST | Milestone Pharmaceuticals | 0.54 | ||||
| LUMO | Lumos Pharma | 0.23 | ||||
| ELYM | Eliem Therapeutics | 2.60 | ||||
| HCWB | HCW Biologics | 20.78 |
Additional Tools for Vaxcyte Stock Analysis
When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.